Article
Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia.
Psychiatric genetics - 1 Aug 2011
Zahari Zalina, Teh Lay Kek, Ismail Rusli, Razali Salleh Mohd
Abstract excerpt
OBJECTIVE: Variations in the gene for dopamine D2 receptor (DRD2) might have an influence on the outcome of antipsychotic treatment in schizophrenia. The objective of this study was to investigate the influence of DRD2 polymorphisms on treatment outcomes in patients with schizophrenia. METHODS: The sample composed of 156 Malaysian outpatients with stable schizophrenia on maintenance antipsychotic treatment at a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
